US2012322689A1PendingUtilityA1
Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
Est. expiryJan 28, 2023(expired)· nominal 20-yr term from priority
A61P 31/18A61P 35/02A61P 31/20A61P 31/00A61P 35/00A61P 31/12A61P 43/00C12N 15/90C12Y 301/00A01K 2227/105A61K 38/00C12N 2840/20C12N 9/22A61K 48/0058C12N 2730/10143A61K 38/1709A61K 38/465C12N 2830/55A01K 2217/00C07K 14/435C12N 2800/80A01K 67/0278C12Y 301/21004C12N 7/00C12N 15/8509C12N 2830/002A01K 2267/03A01K 2217/05C12N 15/1058C12N 15/86C12N 2799/022A01K 2267/0337A01K 2207/15A61K 48/00C12N 2840/44C12N 15/907C07K 2319/81A01K 67/0275
56
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides a method for detecting nucleic acid cleavage induced by a modified rare-cutting endonuclease derived from an initial rare-cutting endonuclease, said modified rare-cutting endonuclease being able to cleave a DNA target sequence, which may be different from the recognition and cleavage site of the initial rare-cutting endonuclease. In one embodiment of the invention expression of a marker gene is used as an indicator of target DNA cleavage.
Claims
exact text as granted — not AI-modified1 . A method for detecting a nucleic acid cleavage induced by a modified rare-cutting endonuclease derived from an initial rare-cutting endonuclease, said modified rare-cutting endonuclease being able to cleave a DNA target sequence, said method comprising:
(i) providing a host cell containing a genetic construct comprising an inactivated marker gene, said marker gene being inactivated by an internal duplication thereof, the internal duplication sequences being separated by an intervening sequence comprising a target DNA sequence to be tested for cleavage, wherein said target DNA sequence is identical to or different from that recognized and cleaved by the initial rare-cutting endonuclease; and (ii) introducing into said cell one or more nucleic acid molecules encoding the modified rare-cutting endonuclease, and (iii) detecting expression of said marker gene, wherein expression of said gene indicates its activation by genetic recombination upon cleavage of said target DNA sequence by said modified rare-cutting endonuclease.
2 . The method of claim 1 , wherein the marker gene is integrated into the genome of the cell.
3 . The method of claim 1 , wherein the internal duplication is at least 50 base pairs in length.
4 . The method of claim 1 , wherein the internal duplication is at least 200 base pairs in length.
5 . The method of claim 1 , wherein the marker gene encodes:
(i) a positive marker; or (ii) a negative marker.
6 . The method of claim 1 , wherein said marker gene encodes beta-galactosidase or a fluorescent protein.
7 . The method of claim 1 , wherein the intervening sequence comprises a second marker gene.
8 . The method of claim 1 , wherein the modified rare-cutting endonuclease is a double-stranded endonuclease having a target DNA sequence of at least 12 base pairs.
9 . The method of claim 1 , wherein the modified rare-cutting endonuclease is:
(i) a group I intron encoded endonuclease; (ii) a zinc-finger protein; or (iii) a nuclease fused to a DNA binding domain.
10 . The method of claim 9 , wherein the modified rare-cutting endonuclease is a homing endonuclease.
11 . The method of claim 1 , wherein said intervening sequence comprises a target DNA sequence that is different from that cleaved by said initial rare-cutting endonuclease.
12 . The method of claim 1 , wherein said intervening sequence comprises a target DNA sequence that is identical to that cleaved by said initial rare-cutting endonuclease.
13 . The method of claim 1 , further comprising mutating the nucleic acid molecules encoding said modified rare-cutting endonuclease to modify the cleavage specificity thereof.
14 . The method of claim 1 , wherein the modified rare-cutting endonuclease recognizes and cleaves a target DNA sequence that is different from that of the initial rare-cutting endonuclease.
15 . The method of claim 1 , wherein said DNA target sequence is derived from a genome where cleavage is desired.
16 . The method of claim 1 , wherein said cell is a yeast cell.
17 . The method according to claim 16 , wherein the cell of step (i) is a yeast cell having a construct comprising said target DNA sequence is cloned into a yeast replicative plasmid.
18 . The method of claim 17 , wherein step (ii) consists of mating said yeast cell of step i) with another yeast cell comprising said nucleic acid molecule encoding the modified rare-cutting endonuclease.
19 . The method of claim 18 , wherein said nucleic acid molecule encoding the modified rare-cutting endonuclease is included in expression vector.
20 . Use of the method according to claim 1 , for the screening of a modified rare-cutting endonuclease library, in order to detect cleavage of a target DNA by one or more modified rare-cutting endonucleases included within said library.
21 . Use of the method according to claim 1 , for the screening of a target DNA library, in order to detect cleavage of a target DNA by a modified rare-cutting endonucleases.
22 . The method according to claim 20 , further comprising the step of isolating the cells, in which expression of the marker gene is detected.
23 . The method according to claim 22 , further comprising the step of isolating the nucleic acid encoding said modified rare-cutting endonuclease from said isolated cell.
24 . The method of claim 21 , further comprising the step of isolating the target DNA cleaved by the modified rare-cutting endonuclease.Join the waitlist — get patent alerts
Track US2012322689A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.